Sofosbuvir and Ribavirin for Treatment of Compensated Recurrent Hepatitis C Virus Infection After Liver Transplantation

Title
Sofosbuvir and Ribavirin for Treatment of Compensated Recurrent Hepatitis C Virus Infection After Liver Transplantation
Authors
Keywords
Antiviral Agent, DAA, Clinical Trial, NS5B Polymerase Inhibitor
Journal
GASTROENTEROLOGY
Volume 148, Issue 1, Pages 108-117
Publisher
Elsevier BV
Online
2014-10-09
DOI
10.1053/j.gastro.2014.10.001

Ask authors/readers for more resources

Reprint

Contact the author

Discover Peeref hubs

Discuss science. Find collaborators. Network.

Join a conversation

Ask a Question. Answer a Question.

Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.

Get Started